Concepedia

Vladimir Dobronravov

VD

17

Publications

1.2K

Citations

13

H-Index

2003

Active since

Affiliations

First Pavlov State Medical University of St. Petersburg(Current)

University College London

Seoul National University Hospital

The Ohio State University

Sorbonne Université

Vladimir Dobronravov is an author at First Pavlov State Medical University of St. Petersburg specializing in medicine, nephrology, and chronic kidney disease.

ORCID

Top concepts

Publications per year

2003–2023

17

Publications

17

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

Brad H. Rovin, Neil Solomons, William F. Pendergraft et al. · Kidney International · 2018 · 290 citations

, , +12

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Éric Rondeau, Marie Scully, Gema Ariceta et al. · Kidney International · 2020 · 203 citations · Full text

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial

Richard A. Brigandi, Brendan M. Johnson, Coreen Oei et al. · American Journal of Kidney Diseases · 2016 · 159 citations · Full text

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

Early referral and planned initiation of dialysis: what impact on quality of life?

Fergus Caskey, Sarah Wordsworth, Thomas Ben et al. · Nephrology Dialysis Transplantation · 2003 · 92 citations · Full text

Rows per page

1–5 of 17